alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 99.2
March 5, 1997

Deloitte & Touche LLP
50 South Main Street
Suite 1800
Salt Lake City, Utah 84144

In connection with your examination relating to our assertion that First 
Security Bank, N.A. (the "Company") has complied with the minimum servicing 
standards set forth in the Mortgage Bankers Association of America's "Uniform 
Single Attestation Program for Mortgage Bankers" (USAP) as of and for the year
ended December 31, 1996 for the First Security Auto Grantor Trust 1995-A (the 
Auto Loan Pool), for the purpose of expressing an opinion as to whether our 
assertion is fairly stated, we make the following representations, to the best
of our knowledge and belief, as of the date of this letter:

1.  We are responsible for the representations made herein and the 
appropriateness of the measurement and disclosure criteria on which they are 
based.

2.  We are responsible for establishing and maintaining an effective internal 
control structure over compliance with the minimum servicing standards.

3.  We have made available all significant information that is relevant to your
examination related to our compliance with the standards in the USAP, as 
applicable to the Auto Loan Pool.

4.  We have performed an evaluation of the Company's compliance with the 
minimum servicing standards in the USAP, as applicable to the Auto Loan Pool.

5.  There are no instances of noncompliance with the standards in the USAP as
applicable to the Auto Loan Pool.

6.  We have disclosed to you all communications that we received from 
regulatory agencies, secondary market agencies, and investors that relate to 
compliance with the Company's servicing agreements.

7.  The data files provided to Lewtan are complete and accurate and include 
all activity affecting the Auto Loan Pool for the respective periods.

8.  All transfers from the Company's operating accounts to the Trustee were in
accordance with the applicable agreements and in agreement with the Lewtan 
reports.

9.  There have been no instances of noncompliance subsequent to the date of 
this letter.

10.  For the year ended December 31, 1996, the Company has complied with the 
minimum servicing standards set forth in the USAP.


(Signed)                                                        March 5, 1997
Spencer F. Eccles, Chairman and Chief Executive Officer


(Signed)                                                        March 5, 1997
Scott C. Ulbrich, Executive Vice President and
  Chief Financial Officer


(Signed)                                                        March 5, 1997
Gayle Nye, Senior Vice President and
  Manager Small Business and Consumer Loan Servicing


(Signed)                                                        March 5, 1997
Sharlene Hill, Assistant Vice President
  Comptroller's Department
**CBI An** **aly tical** 

**Method CBI**  **Composition** Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y YNOT CBI-HFC Emissions

NOT CBI-Isocyanate emission from curing polyurethane adhesives NOT CBI-Quantification of HFC Blowing Agent Emissions of Typical Appliance Insulating Foam by SL Aprahamian and JM Bowman API 2005 NOT CBI-Spray Foam EmissionsCBI

Y Y Y N N

N NThe following are methods which are used in isocyanate manufacture and product testing,

and are provided as background information for the analytical data being provided.

Method CBI Y Y Y Y Y Y Y Y Y Y Y Y NOT CBI--ASTM Reactivity.pdf NMethod CBI Y Y YCBI

NOT CBI - Bayer CPI paper Re-occupancy N Not CBI - CPI Conf paper -Bayer SPF study N NOT CBI - BMS SPF reoccupancy ltr 10-25-2011 N Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y YCBI

Composition CBIProduct Information Bulletins

Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Technical DatasheetsCBIMaterial Safety Data Sheets CBI

N N N N N N N N N N N N N N N N N N N N N N N N N N N N N N N N Login for Material Safety Data SheetsReport CBI Y Y Y YReport

Not CBI--BMS SPF Industrial Hygiene Reports Not CBI--BMS Sampling Analytical MethodsCBI

Y Y Y Y Y Y Y N N Y Y
<PAGE>   1
               CONSENT OF FORTNER, BAYENS, LEVKULICH AND CO., P.C.

                                  EXHIBIT 23.1

                       CONSENT OF INDEPENDENT ACCOUNTANTS'



To Board of Directors
Front Range Capital Corporation


         We consent to the use in the Form 10-QSB of Front Range Capital
Corporation for the quarterly period ended March 31, 2001 our report dated May
1, 2001 relating to the consolidated balance sheet of Front Range Capital
Corporation and subsidiaries as of March 31, 2001 and the related consolidated
statements of income, stockholders' equity and cash flows for the three-month
period then ended.







                                    /s/ Fortner, Bayens, Levkulich & Co., P.C.

Denver, Colorado
May 14, 2001
<PAGE>   1

                                                                  EXHIBIT 21.1


SUBSIDIARIES OF THE COMPANY

         MiniMed Distribution Corp., a Delaware corporation 

         MiniMed International, Inc., a Barbados corporation 

         MiniMed Development Corp. a Delaware corporation 

         MiniMed SA, a French corporation 

         MiniMed GMBH, a German corporation 

         Dartec AB, a Swedish corporation 

         Home Medical Supply, Inc., a Florida corporation 

         Home Medical Supply, Inc., a Georgia corporation 

         Home Medical Supply, Inc., a Tennessee corporation

         Home Medical Supply, Inc., a California corporation 

         Home Medical Supply of Michigan, Inc., a Michigan corporation 

         HMS, Inc., an Alabama corporation 

         Pharmax, Inc., a Florida corporation 
         d/b/a Home Medical Supply, Inc. 

         South Broward Medical Arts Pharmacy, Inc., a Florida corporation 

         Clark Pharmacy, Inc., a Georgia corporation 

         Clark Wholesale Co., a Florida corporation 

         Diabetix Depot, Inc., a Florida corporation
         
         Dialysis Management Services, Inc., a Florida corporation 

         Medical Management & Marketing of South Florida, a Florida corporation
STEAM ELECTRIC CBI REPLACEMENT PAGE

EPA

- HQ

- OW

- 200 9-0 819

DCN: SE01295A9

THE FOLLOWING HAS BEEN REMOVED BECAUSE IT

CONTAINS CONFIDENTIAL BUSINESS I NFORMATION

(CBI) PER 40 CFR PART 2, SUBPART B.
##### 



EXHIBIT 10.19
 FORM OF BOND
  R-1
    
    $1,600,000
 
 
        IN ACCORDANCE WITH RCW 43.163.140(1), THIS BOND SHALL NOT BE DEEMED TO CONSTITUTE A DEBT,
LIABILITY OR GENERAL OBLIGATION OF THE AUTHORITY, THE STATE OF WASHINGTON OR ANY POLITICAL
SUBDIVISION THEREOF, OR A PLEDGE OF THE FAITH AND CREDIT OF THE AUTHORITY, THE STATE OF WASHINGTON
OR ANY SUCH POLITICAL SUBDIVISION, BUT IS A SPECIAL OBLIGATION PAYABLE SOLELY FROM THE REVENUES AND
PROCEEDS PROVIDED THEREFOR. NEITHER THE AUTHORITY, THE STATE OF WASHINGTON OR ANY POLITICAL
SUBDIVISION THEREOF SHALL BE OBLIGATED TO PAY THE PRINCIPAL OF, INTEREST OR PREMIUM, IF ANY, ON
THIS BOND, AND NEITHER THE FAITH AND CREDIT NOR ANY TAXING POWER OF THE STATE OF WASHINGTON OR ANY
POLITICAL SUBDIVISION THEREOF IS PLEDGED TO THE PAYMENT OF THE PRINCIPAL OF, THE INTEREST OR
PREMIUM, IF ANY, ON THIS BOND. THE AUTHORITY HAS NO TAXING POWER.




---



##### 



WASHINGTON ECONOMIC DEVELOPMENT FINANCE AUTHORITYBy:
    
    /s/ Robert P. Meredith

ChairAttest:/s/ Jonathan A. Hayes

Executive Director
 CERTIFICATE OF AUTHENTICATION AND REGISTRATION
 th
  WASHINGTON ECONOMIC DEVELOPMENT FINANCE AUTHORITYBy:
    
    /s/ Jonathan A. HayesExecutive Director
 2
Exhibit 99.5

[Letterhead]

Report of Independent Accountants

Target
Corporation,
Its Officers and Directors
        and
Target Receivables Corporation,
Its Officers and Directors
As Transferor
        and
Retailers National Bank,
Its Officers and Directors
As Servicer
        and
Wells Fargo Bank, National Association
As Trustee

We
have audited, in accordance with auditing standards generally accepted in the United States, the statements of financial condition of Retailers National Bank (the Bank) as of December 31,
2001 and 2000, and the related statements of income, stockholders' equity, and cash flows for the years then ended and have issued our report thereon dated January 25, 2002.

Our
audit, referred to in the preceding paragraph, included procedures applied to the documents and records relating to the servicing of credit card receivables under the Amended and Restated Target
Credit Card Master Trust Pooling and Servicing Agreement (the Pooling and Servicing Agreement), dated as of August 22, 2001. Our procedures were as follows:

Documents
and records relating to the servicing of credit card receivables under the Pooling and Servicing Agreement:



The
results of the procedures described above provided satisfactory evidential matter for the purposes of our audit of the financial statements, referred to in the introductory paragraph of this
letter, taken as a whole. The administration and servicing appear to be conducted in compliance with Article III and Article IV and Section 8.8 of the Pooling and Servicing Agreement insofar as
such Articles and Section relate to accounting matters.

This
report is intended solely for the use of the specified users listed above and should not be used by those who have not agreed to the procedures and taken responsibility for the sufficiency of the
procedures for their purposes. However, this report is a matter of public record, as a result of inclusion as an exhibit to the Annual Report on Form 10-K filed by Target Receivables Corporation on
behalf of the Trust, and its distribution is not limited.

|                 |  |  |  | Very truly yours,
|---------------- |  |  |  | -----------------
|                 |  |  |  |                  
|January 25, 2002 |  |  |  |                  



QuickLinks
<TABLE> <S> <C>

<ARTICLE>                5

<LEGEND>
THIS SCHEDULE  CONTAINS SUMMARY  FINANCIAL  INFORMATION  EXTRACTED FROM AVITAR'S
QUARTERLY  REPORT FOR THE QUARTER  ENDED MARCH 31, 2000 AND IS  QUALIFIED IN ITS
ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>



<S>                                                    <C>
<PERIOD-TYPE>                                    6-MOS
<FISCAL-YEAR-END>                                      SEP-30-2000
<PERIOD-START>                                         OCT-1-1999
<PERIOD-END>                                           MAR-31-2000
<CASH>                                                   1,488,213
<SECURITIES>                                                     0
<RECEIVABLES>                                              806,685
<ALLOWANCES>                                                90,000
<INVENTORY>                                                425,358
<CURRENT-ASSETS>                                         2,737,458
<PP&E>                                                   1,320,307
<DEPRECIATION>                                             974,957
<TOTAL-ASSETS>                                           5,982,154
<CURRENT-LIABILITIES>                                    1,687,944
<BONDS>                                                          0
<PREFERRED-MANDATORY>                                            0
<PREFERRED>                                                 20,634
<COMMON>                                                   280,322
<OTHER-SE>                                               3,878,006
<TOTAL-LIABILITY-AND-EQUITY>                             5,982,154
<SALES>                                                  1,620,209
<TOTAL-REVENUES>                                         1,620,209
<CGS>                                                    1,344,976
<TOTAL-COSTS>                                            4,613,155
<OTHER-EXPENSES>                                                 0
<LOSS-PROVISION>                                                 0
<INTEREST-EXPENSE>                                          42,425
<INCOME-PRETAX>                                         (2,999,456)
<INCOME-TAX>                                                     0
<INCOME-CONTINUING>                                     (2,999,456)
<DISCONTINUED>                                                   0
<EXTRAORDINARY>                                                  0
<CHANGES>                                                        0
<NET-INCOME>                                            (2,999,456)
<EPS-BASIC>                                                   (.13)
<EPS-DILUTED>                                                 (.13)


</TABLE>
# C_2015065EN.01001801.xml

| 23.2.2015 | EN | Official Journal of the European Union | C 65/18 |
| --- | --- | --- | --- |

23.2.2015

EN

Official Journal of the European Union

C 65/18

---

Request for a preliminary ruling from the Landgericht Münster (Germany) lodged on 12 November 2014 — Klausner Holz Niedersachsen GmbH v Land Nordrhein-Westfalen

(Case C-505/14)

(2015/C 065/26)

Language of the case: German

Referring court

Referring court

Landgericht Münster

Parties to the main proceedings

Parties to the main proceedings

Applicant: Klausner Holz Niedersachsen GmbH

Applicant:

Defendant: Land Nordrhein-Westfalen

Defendant:

Question referred

Question referred

In civil proceedings concerning the performance of a civil-law contract granting aid, does EU law, in particular Articles 107 TFEU and 108 TFEU (or Articles 87 TEC and 88 TEC) and the principle of effectiveness, require that a final declaratory judgment under civil law which has been delivered in the same case and which confirms that the civil-law contract remains in force, without any consideration of the law on aid, be disregarded if under national law the performance of the contract cannot otherwise be prevented?

---
Exhibit
23.2








Consent
of Independent Registered Public Accounting Firm





We
consent to the incorporation by reference in the following Registration
Statements:





(1)
Registration Statement (Form S-3 No. 333-86105, Form S-3 No. 333-35206, Form S-3
No. 333-72614, Form S-3 No. 333-82596, Form S-3 No. 333-101666, Form S-3 No.
333-107836, Form S-3 No. 333-111360, Form S-3 No. 333-118595, Form S-3 No.
333-121297, Form S-3 No. 333-122887, Form S-3 No. 333-128929, Form S-3 No.
333-133786, Form S-3 No. 333-139173, Form S-3 No. 333-151536, Form S-3 No.
333-151654, and Form S-3 No. 333-156237) of Discovery Laboratories, Inc. and in
related Prospectuses,





(2)
Registration Statement (Form S-8 No. 333-148028) pertaining to the Discovery
Laboratories, Inc. 2007 Long-Term Incentive Plan,





(3)
Registration Statement (Form S-8 No. 333-33900, Form S-8 No. 333-55900, Form S-8
No. 333-67422. Form S-8 No. 333-100824,  Form S-8 No. 333-109274, Form
S-8 No. 333-116268, Form S-8 No. 333-127790, and Form S-8 No. 333-138476)
pertaining to the Amended and Restated 1998 Stock Incentive Plan of Discovery
Laboratories, Inc.,





(4)
Registration Statement (Form S-8 No. 333-59945) pertaining to the Amended and
Restated 1998 Stock Incentive Plan of Discovery Laboratories, Inc., Discovery
Laboratories, Inc. 1996 Stock Option/Stock Issuance Plan and Acute Therapeutics,
Inc. 1996 Stock Option/ Stock Issuance Plan,





(5)
Registration Statement (Form S-8 No. 333-37975) pertaining to the Restated 1993
Stock Option Plan of Ansan Pharmaceuticals, Inc. and the 1995 Stock Option Plan
of Ansan Pharmaceuticals, Inc., and





(6)
Registration Statement (Form S-8 No. 333-110412, Form S-8 No. 333-137643, Form
S-8 No. 333-156443, Form S-8 No. 333-164470, Form S-8 No. 333-165809, and Form
S-8 No. 333-169662) pertaining to the 401(k) Plan of Discovery Laboratories,
Inc.





of our
report dated March 10, 2010, except for Note 2, Note 4, and Note 5, as to which
the date is November 12, 2010 with respect to the consolidated financial
statements of Discovery Laboratories, Inc. and subsidiary and of our report
dated March 10, 2010 except for the effects of the material weakness described
in the sixth paragraph of that report, as to which the date is November 12,
2010, with respect to the effectiveness of internal control over financial
reporting of Discovery Laboratories, Inc. and subsidiary, included in this
Annual Report (Form 10-K/A) of Discovery Laboratories, Inc. and subsidiary for
the year ended December 31, 2009.








/s/ Ernst
& Young LLP





Philadelphia,
Pennsylvania


November
12, 2010
IN THE SUPREME COURT OF PENNSYLVANIA

EASTERN DISTRICT

CARL SADLER,

Petitioner

v.

PHILADELPHIA COCA-COLA (WORKERS' 

COMPENSATION APPEAL BOARD),

Respondent

:

:

:

:

:

:

:

:

:

:

:

:

No. 34 EAL 2022

Petition for Allowance of Appeal 

from the Order of the 

Commonwealth Court

ORDER

PER CURIAM

AND NOW, this 19th day of July, 2022, the Petition for Allowance of Appeal is 

DENIED.
§ 812.145 Inspections. ( a ) *Entry and inspection.* A sponsor or an investigator who has authority to grant access shall permit authorized FDA employees, at reasonable times and in a reasonable manner, to enter and inspect any establishment where devices are held (including any establishment where devices are manufactured, processed, packed, installed, used, or implanted or where records of results from use of devices are kept).
( b ) *Records inspection.* A sponsor, IRB, or investigator, or any other person acting on behalf of such a person with respect to an investigation, shall permit authorized FDA employees, at reasonable times and in a reasonable manner, to inspect and copy all records relating to an investigation.
( c ) *Records identifying subjects.* An investigator shall permit authorized FDA employees to inspect and copy records that identify subjects, upon notice that FDA has reason to suspect that adequate informed consent was not obtained, or that reports required to be submitted by the investigator to the sponsor or IRB have not been submitted or are incomplete, inaccurate, false, or misleading.
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          SEP-30-1998
<PERIOD-START>                              APR-1-1998
<PERIOD-END>                               JUN-30-1998
<CASH>                                             477
<SECURITIES>                                         0
<RECEIVABLES>                                   64,684
<ALLOWANCES>                                         0
<INVENTORY>                                     47,334
<CURRENT-ASSETS>                               114,968
<PP&E>                                               0
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                 267,464
<CURRENT-LIABILITIES>                           76,236
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        24,969
<OTHER-SE>                                      51,475
<TOTAL-LIABILITY-AND-EQUITY>                   267,464
<SALES>                                        137,625
<TOTAL-REVENUES>                               137,625
<CGS>                                           96,143
<TOTAL-COSTS>                                  121,230
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               2,287
<INCOME-PRETAX>                                 14,108
<INCOME-TAX>                                     4,938
<INCOME-CONTINUING>                              9,170
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     9,170
<EPS-PRIMARY>                                       78
<EPS-DILUTED>                                       68
        

</TABLE>
Exhibit 13.1

Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of
Title 18, United States Code), each of the undersigned officers of Deutsche Telekom AG (the "Company"), does hereby certify, to such officer's knowledge, that:

The
Annual Report on Form 20-F for the year ended December 31, 2005, of the Company fully complies with the requirements of Section 13(a) or
15(d) of the Securities Exchange Act of 1934, and information contained in the Form 20-F fairly presents, in all material respects, the financial condition and results of
operations of the Company.

|Dated: March 14, 2006 |  | /s/KAI-UWE RICKEKai-Uwe Ricke
Chairman of the Management Board                                               
|--------------------- |  | -------------------------------------------------------------------------------------------------------------
|                      |  |                                                                                                              
|Dated: March 14, 2006 |  | /s/DR. KARL-GERHARD EICKDr. Karl-Gerhard Eick
Deputy Chairman of the Management Board
Finance and Controlling

---



QuickLinks
§ 74.2707 D&C Yellow No. 7. ( a ) *Identity and specifications.* The color additive D&C Yellow No. 7 shall conform in identity and specifications to the requirements of § 74.1707(a)(1) and (b).
( b ) *Uses and restrictions.* D&C Yellow No. 7 may be safely used for coloring externally applied cosmetics in amounts consistent with good manufacturing practice.
( c ) *Labeling.* The label of the color additive shall conform to the requirements of § 70.25 of this chapter.
( d ) *Certification.* All batches of D&C Yellow No. 7 shall be certified in accordance with regulations in part 80 of this chapter.
# C_2014102EN.01002701.xml

| 7.4.2014 | EN | Official Journal of the European Union | C 102/27 |
| --- | --- | --- | --- |

7.4.2014

EN

Official Journal of the European Union

C 102/27

---

Action brought on 18February 2014 — European Commission v Ireland

(Case C-87/14)

2014/C 102/37

Language of the case: English

Parties

Parties

Applicant: European Commission (represented by: J. Enegren, M. van Beek, Agents)

Applicant:

Defendant: Ireland

Defendant:

The applicant claims that the Court should:

The applicant claims that the Court should:

| — | declare that:by failing to apply the provisions of Directive 2003/88/EC (1) of the European Parliament and of the Council of 4 November 2003 concerning certain aspects of working time to the organisation of the working time of junior doctors (non-consultant hospital doctors), Ireland has failed to fulfil its obligations under Article 3, 5, 6, 17(2) and 17(5) of the Directive. |
| --- | --- |

—

declare that:by failing to apply the provisions of Directive 2003/88/EC (1) of the European Parliament and of the Council of 4 November 2003 concerning certain aspects of working time to the organisation of the working time of junior doctors (non-consultant hospital doctors), Ireland has failed to fulfil its obligations under Article 3, 5, 6, 17(2) and 17(5) of the Directive.

1

| — | order Ireland to pay the costs. |
| --- | --- |

—

order Ireland to pay the costs.

Pleas in law and main arguments

Pleas in law and main arguments

Article 3

Ireland has failed to ensure, with regard to junior doctors, that they are provided with the minimum daily rest period per 24 hours.

Article 5

Ireland has failed to ensure that junior doctors are provided with the minimum uninterrupted rest period per each seven day period.

Article 6

Ireland has failed to ensure that that the average working time for each seven day period does not exceed 48 hours.

Article 17(2)

Ireland has failed to ensure that junior doctors are afforded equivalent periods of compensatory rest when required to work without having recourse to the rest periods indicated in Articles 3 and 5.

Article 17(5)

Ireland has not ensured that doctors in training do not exceed the weekly working time after the end of the transitional period laid down in Article 17(5).

---

(1)  OJ L 299, p. 9

1

---